Boston Scientific (BSX) EVP Padraig O'Connor Receives 1,171 Shares

What Happened

• Padraig O'Connor, EVP, Global Operations at Boston Scientific, had 1,171 derivative units converted into 1,171 shares on Sept 2, 2026 (transaction code M). The conversion carried no exercise price ($0.00 per share). To satisfy tax withholding, 567 of the shares were surrendered (transaction code F) at $48.37 per share, totaling $27,426. A separate Form 4 line records the conversion/disposition of the 1,171 derivative units.

Key Details

• Transaction date: 2026-09-02
• Conversion: 1,171 shares from derivative/units @ $0.00 (code M)
• Tax withholding: 567 shares disposed @ $48.37 = $27,426 (code F)
• Filing date: 2026-09-03 (no late filing indicated)
• Shares owned after the transaction: not specified in the provided filing
• Footnotes:
  • F1: Each restricted stock unit (RSU) represents a commitment to issue one share.
  • F2: Includes shares acquired under the Employee Stock Purchase Plan (contextual).
  • F3: Shares will be issued in four equal annual installments beginning Sept 2, 2026.

Context

• This appears to be a routine conversion/vesting of restricted-equity units with a net share settlement to cover tax withholding (567 shares withheld). Such tax-withholdings are common and do not necessarily signal buying or selling intent in the open market.